MP
MapLight Therapeutics, Inc.
MPLT · NASDAQ
$10.92 -2.59% (-$0.29)
1M -3.87%
Market Cap $463.4M
P/E Ratio -
Div. Yield -
ROE 63.84%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 1.33x
PEG N/A
P/S N/A
Growth
100 /100
Growing Book val. growth 180.05%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 63.84%
ROA 62.39%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 16.52x
Debt/Equity 0.01x
Net debt/EBITDA N/A
Stability
30 /100
Unstable EPS volatility 30.04%
Profitable years 0
Beta 2.57x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MPLT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher A. Kroeger
Employees
133
Headquarters
Redwood City
Prihajajoči dogodki
03 DEC.
Earnings
Upcoming earnings report